Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes

Examination of efficacy of olmesartan on peripheral insulin sensitivity in Japanese patients with type 2 diabetes - olmesartan - IR study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005535

Enrollment

Registered

2011-05-09

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Type 2 diabetes mellitus

Interventions

olmesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive subjects (office blood pressure &#8805; 140/90 mmHg) with type 2 diabeteswho visited our medical institutions as outpatients and have never been administrated any antihypertensive treatment

Exclusion criteria

Exclusion criteria: subjects treated with corticosteroids are excluded from this study. In addition, subjects with secondary hypertension, severe renal and hepatic disease, overt cardiovascular disease, or malignancy are excluded.

Design outcomes

Secondary

Measure	Time frame
HbA1c total adiponectin systolic/diastolic blood pressure	—

Primary

Measure	Time frame
M/I-value	—

Countries

Japan

Contacts

Public ContactSeiya Shimoda

Kumamoto University Department of Metabolic Medicine, Faculty of Life Sciences

sshimoda@gpo.kumamoto-u.ac.jp+81-96-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026